Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Prostate Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/19/2019 |
| Start Date: | March 1, 2019 |
| End Date: | March 2021 |
| Contact: | Laura Gross |
| Email: | laura.gross@jefferson.edu |
| Phone: | 215-503-5285 |
The EMPOWeR study is proposed as a cohort study with longitudinal follow-up to determine
rates of genetic mutations among men with or at-risk for prostate cancer to address the
various facets of genetic education and counseling for optimized genetic assessment and
wellness of men. The results will inform practice guidelines and future studies for maximal
impact of genetic evaluation of men for inherited prostate cancer.
rates of genetic mutations among men with or at-risk for prostate cancer to address the
various facets of genetic education and counseling for optimized genetic assessment and
wellness of men. The results will inform practice guidelines and future studies for maximal
impact of genetic evaluation of men for inherited prostate cancer.
Inclusion Criteria:
- Men with a personal history of prostate cancer
- Unaffected males who are at higher risk for prostate cancer (family history of
prostate cancer or African American males)
- Men who previously tested positive for a mutation may be eligible for Specific Aims
2-7
- Men with a known familial mutation
- Men who previously participated in the Genetic Evaluation of Men (GEM) study
(IRB#14S.546) will be offered participation in EMPOWeR -
Exclusion Criteria:
- Age < 18 years
- Mental or cognitive impairment that interferes with ability to provide informed
consent
We found this trial at
1
site
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
Click here to add this to my saved trials
